Cullinan Oncology
CGEM
CGEM
66 hedge funds and large institutions have $762M invested in Cullinan Oncology in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 33 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 71 → 66 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Holders
66
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$30.1M | |
| 2 | +$18.4M | |
| 3 | +$14M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.04M |
| 5 |
Goldman Sachs
New York
|
+$3.88M |
Top Sellers
| 1 | -$7.61M | |
| 2 | -$7.22M | |
| 3 | -$7.1M | |
| 4 |
PVI
Pura Vida Investments
New York
|
-$4.26M |
| 5 |
EP
Eversept Partners
New York
|
-$4.22M |